Department of Radiation Oncology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):590-5. doi: 10.1016/j.ijrobp.2012.01.029. Epub 2012 Mar 22.
In light of concerns regarding the quality of radiation treatment delivery, we surveyed the practice of quality assurance peer review chart rounds at American academic institutions.
An anonymous web-based survey was sent to the chief resident of each institution across the United States.
The response rate was 80% (57/71). The median amount of time spent per patient was 2.7 minutes (range, 0.6-14.4). The mean attendance by senior physicians and residents was 73% and 93%, respectively. A physicist was consistently present at peer review rounds in 66% of departments. There was a close association between attendance by senior physicians and departmental organization: in departments with protected time policies, good attendance was 81% vs. 31% without protected time (p = 0.001), and in departments that documented attendance, attending presence was 69% vs. 29% in departments without documentation (p < 0.05). More than 80% of institutions peer review all external beam therapy courses; however, rates were much lower for other modalities (radiosurgery 58%, brachytherapy 40%-47%). Patient history, chart documentation, and dose prescription were always peer reviewed in >75% of institutions, whereas dosimetric details (beams, wedges), isodose coverage, intensity-modulated radiation therapy constraints, and dose-volume histograms were always peer reviewed in 63%, 59%, 42%, and 50% of cases, respectively. Chart rounds led to both minor (defined as a small multileaf collimator change/repeated port film) and major (change to dose prescription or replan with dosimetry) treatment changes. Whereas at the majority of institutions changes were rare (<10% of cases), 39% and 11% of institutions reported that minor and major changes, respectively, were made to more than 10% of cases.
The implementation of peer review chart rounds seems inconsistent across American academic institutions. Brachytherapy and radiosurgical procedures are rarely reviewed. Attendance by senior physicians is variable, but it improves when scheduling clashes are avoided. The potential effect of a more thorough quality assurance peer review on patient outcomes is not known.
鉴于人们对放射治疗实施质量的担忧,我们对美国学术机构的质量保证同行评审图表轮次实践情况进行了调查。
我们向美国各地的每个机构的住院总医师发送了一份匿名的网络调查。
回复率为 80%(57/71)。每位患者的平均审查时间为 2.7 分钟(范围:0.6-14.4)。高级医师和住院医师的平均出席率分别为 73%和 93%。在 66%的科室中,物理学家始终出席同行评审轮次。高级医师的出席情况与科室组织密切相关:在有保护时间政策的科室中,良好的出席率为 81%,而无保护时间的科室为 31%(p=0.001);在有记录出席情况的科室中,实际出席率为 69%,而无记录的科室为 29%(p<0.05)。超过 80%的机构对所有外部束治疗课程进行同行评审;然而,其他模式(放射外科 58%、近距离放射治疗 40%-47%)的比率要低得多。病史、图表记录和剂量处方始终在超过 75%的机构中进行同行评审,而剂量学细节(射束、楔形板)、等剂量覆盖、调强放疗约束和剂量-体积直方图分别在 63%、59%、42%和 50%的病例中进行同行评审。图表轮次导致了轻微(定义为小多叶准直器变化/重复端口片)和重大(剂量处方改变或重新计划剂量学)治疗改变。尽管在大多数机构中,这种改变很少见(<10%的病例),但 39%和 11%的机构报告称,轻微和重大改变分别在 10%以上的病例中进行。
在美国学术机构中,同行评审图表轮次的实施似乎不一致。近距离放射治疗和放射外科手术很少进行审查。高级医师的出席情况不一,但当避免时间冲突时,出席情况会有所改善。更彻底的质量保证同行评审对患者结局的潜在影响尚不清楚。